Alumis (ALMS) EBITDA (2023 - 2026)
Alumis' (ALMS) quarterly EBITDA came in at -$148.9 million in Q2 2026, down 5.92% year-over-year from -$158.2 million in Q2 2025, and down 54.34% quarter-over-quarter from -$96.4 million in Q4 2025.
Analysis
Alumis (ALMS) EBITDA (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported EBITDA for 4 consecutive years, with -$148.9 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA fell 5.92% year-over-year to -$148.9 million in Q2 2026; TTM through Jun 2026 was -$501.1 million, a 14.13% decrease from a year earlier, with the FY2025 full-year figure at -$453.8 million, down 50.89% from the prior year.
- EBITDA was -$148.9 million for Q2 2026 at Alumis, down from -$96.4 million in the prior quarter.
- Over five years, EBITDA peaked at -$37.6 million in Q2 2023 and troughed at -$148.9 million in Q2 2026.
- A 4-year average of -$85.4 million and a median of -$97.4 million in 2024 frame the typical range for EBITDA.
- The widest YoY moves for EBITDA: up 2.21% in 2025, down 150.34% in 2025.
- Over 4 years, EBITDA stood at -$40.1 million in 2023, then sank by 145.74% to -$98.6 million in 2024, then increased by 2.21% to -$96.4 million in 2025, then plunged by 54.34% to -$148.9 million in 2026.
- The last three EBITDA figures came in at -$148.9 million (Q2 2026), -$96.4 million (Q4 2025), and -$115.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -365.99 Mn |
| 10 | Alumis | 1.27 Bn | 765.76 Mn | - | -148.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -148.86 Mn |
| Dec 31, 2025 | -96.45 Mn |
| Sep 30, 2025 | -115.29 Mn |
| Jun 30, 2025 | -140.54 Mn |
| Mar 31, 2025 | -101.53 Mn |
| Dec 31, 2024 | -98.62 Mn |
| Sep 30, 2024 | -98.40 Mn |
| Jun 30, 2024 | -56.14 Mn |
| Mar 31, 2024 | -47.59 Mn |
| Dec 31, 2023 | -40.13 Mn |
| Sep 30, 2023 | -43.76 Mn |
| Jun 30, 2023 | -37.62 Mn |